Delphi Private Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-891
Closed -$60K 59
2018
Q3
$60K Hold
891
0.2% 29
2018
Q2
$52K Hold
891
0.17% 35
2018
Q1
$46K Hold
891
0.18% 37
2017
Q4
$48K Hold
891
0.12% 80
2017
Q3
$54K Sell
891
-52
-6% -$3.15K 0.16% 29
2017
Q2
$58K Hold
943
0.12% 35
2017
Q1
$57K Sell
943
-252
-21% -$15.3K 0.1% 31
2016
Q4
$67K Sell
1,195
-54
-4% -$3.16K 0.12% 33
2016
Q3
$74K Sell
1,249
-440
-26% -$25.7K 0.13% 30
2016
Q2
$93K Buy
1,689
+29
+2% +$1.54K 0.17% 29
2016
Q1
$84K Sell
1,660
-70
-4% -$3.43K 0.15% 32
2015
Q4
$87K Buy
+1,730
New +$87.2K 0.15% 34

Other funds holding MRK

Delphi Private Advisors's MRK Position: Q4 2018 in Review

Delphi Private Advisors sold out of Merck (MRK) in Q4 2018, closing a stake of 891 shares — an estimated $60K sold.

Delphi Private Advisors first reported a position in MRK in Q4 2015 and held it in 12 quarters. The position peaked at $93K in Q2 2016. 2,250 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

  • Delphi Private Advisors reported no remaining Merck position as of Q4 2018 after selling out during the quarter.
  • Delphi Private Advisors sold 891 Merck shares in Q4 2018, an estimated $60K.
  • Delphi Private Advisors first reported a position in Merck in Q4 2015 and held it in 12 quarters.
  • Delphi Private Advisors's Merck position peaked at $93K in Q2 2016.
  • 2,250 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Delphi Private Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.